Walter Pugh
Internal Medicine · Greenville, SCNPI 1770632762
Payments from drug & device makers
Across 606 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$932
- Boehringer Ingelheim$702
- AstraZeneca$684
- Amgen$622
- Amarin Pharma, Inc.$597
- plus $5K from 36 others
What the payments were for
- Food & beverage$10,181100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$126
- QULIPTA$124
- UBRELVY$124
- DEXCOM G6 TRANSMITTER$123
- DEXCOM G7 GSS (161)$120
- FARXIGA$117
How this compares
$10,181 in reported general payments places this provider in the 90th percentile of 1,498 internal medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 32 | $41,589 |
| OzempicSemaglutide | 30 | $29,843 |
| FarxigaDapagliflozin Propanediol | 12 | $20,577 |
| XareltoRivaroxaban | 15 | $18,503 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $8,264 |
| MyrbetriqMirabegron | 12 | $7,434 |
| SynthroidLevothyroxine Sodium | 22 | $1,899 |
| Atorvastatin Calcium | 188 | $1,636 |
| Levothyroxine Sodium | 127 | $1,598 |
| Rosuvastatin Calcium | 110 | $1,493 |
| Metoprolol Succinate | 77 | $1,461 |
| Tamsulosin Hcl | 62 | $1,358 |
| Omeprazole | 98 | $1,327 |
| Potassium Chloride | 52 | $1,250 |
| Gabapentin | 53 | $919 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $702 | $41,58932 claims |
| Novo NordiskOzempic | $1,296 | $29,84330 claims |
| AstraZenecaFarxiga | $684 | $20,57712 claims |
| Johnson & JohnsonXarelto | $539 | $18,50315 claims |
| Astellas Pharma US IncMyrbetriq | $94 | $7,43412 claims |
| AbbVieSynthroid | $932 | $1,89922 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $45 | $1,598127 claims |
| Lilly USA, LLCHumalog | $446 | $65712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Greenville
- Bruce GrayGreenville$254K
- Mark PurcellGreenville$165K
- Melanie GreeneGreenville$142K
- Zion LammGreenville$118K
- Lisa DarbyGreenville$43K
- Uchenna DikeGreenville$31K
- Siddesha ArashinagundiGreenville$13K
- Jill SullivanGreenville$12K
- Sudhhirkumar PatelGreenville$12K
- Rica SantiagoMt Pleasant$10.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.